← Leaderboards
Gerard C Blobe
Duke University
$15,421,046
Attributed
$16,451,889
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,451,889 · 15
By mechanism
R01$12,004,295 · 7
R25$1,704,339 · 2
P30$1,448,784 · 3
K22$457,563 · 1
S10$456,500 · 1
R21$380,408 · 1
Top collaborators
- Johnna M Frierson4 shared
- Jason Andrew Somarelli3 shared
- Robert J Bastidas2 shared
- Micah A. Luftig2 shared
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- Douglas A Marchuk$20,574,970
- Lee Zou$13,956,280
- Micah A. Luftig$19,856,384
- Xiao-Fan Wang$23,927,835
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSignal TransductionBaseTransforming Growth FactorsPathway InteractionsSignal PathwayMediatingCancer CellIn VivoReceptorIn VitroEventTumor ProgressionResearch PersonnelLigandsInsightProgramsCell SurfaceBiological ProcessBinding (Molecular Function)Malignant Breast NeoplasmFundingTumorTransforming Growth Factor Beta Receptors
Grant awards (63)
Cancer Research Training and Education Coordination (CRTEC)$472,914
P30 · FY2025 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$290,185
R25 · FY2025 · GM · contact PI
Duke PRIME Cancer Research Program$217,729
R25 · FY2025 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$289,105
R25 · FY2024 · GM · contact PI
CRCE and Related Activities Core$230,732
P30 · FY2024 · CA · contact PI
Duke PRIME Cancer Research Program$217,729
R25 · FY2024 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$394,579
R01 · FY2023 · CA · contact PI
Role for TbetaRIII Shedding in the Tumor Microenvironment$327,599
R01 · FY2023 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$246,376
R25 · FY2023 · GM · contact PI
CRCE and Related Activities Core$229,364
P30 · FY2023 · CA · contact PI
Duke PRIME Cancer Research Program$196,839
R25 · FY2023 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$189,169
R01 · FY2023 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$425,689
R01 · FY2022 · CA · contact PI
Role for TbetaRIII Shedding in the Tumor Microenvironment$336,648
R01 · FY2022 · CA · contact PI
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program$246,376
R25 · FY2022 · GM · contact PI
CRCE and Related Activities Core$229,361
P30 · FY2022 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$432,644
R01 · FY2021 · CA · contact PI
Role for TbetaRIII Shedding in the Tumor Microenvironment$338,901
R01 · FY2021 · CA · contact PI
CRCE and Related Activities Core$220,825
P30 · FY2021 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$422,572
R01 · FY2020 · CA · contact PI
Role for TbetaRIII Shedding in the Tumor Microenvironment$338,901
R01 · FY2020 · CA · contact PI
Solid Tumor Program$65,588
P30 · FY2020 · CA · contact PI
Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer Biology$387,403
R01 · FY2019 · CA · contact PI
Role for TbetaRIII Shedding in the Tumor Microenvironment$321,420
R01 · FY2019 · CA · contact PI
Dissecting ALK4 Function in Cancer Progression$172,913
R21 · FY2016 · CA · contact PI
Dissecting ALK4 Function in Cancer Progression$207,495
R21 · FY2015 · CA · contact PI
Role of TbRIII in Regulating Motility and Invasion$395,694
R01 · FY2013 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$327,279
R01 · FY2013 · CA · contact PI
Role of TbRIII in Regulating Motility and Invasion$50,873
R01 · FY2013 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$44,607
R01 · FY2013 · CA · contact PI
Role of TbRIII in Regulating Motility and Invasion$423,323
R01 · FY2012 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$350,612
R01 · FY2012 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$36,347
R01 · FY2012 · CA · contact PI
Role of TbRIII in Regulating Motility and Invasion$425,769
R01 · FY2011 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$353,126
R01 · FY2011 · CA · contact PI
Multispectral Imaging Flow Cytometer Core$456,500
S10 · FY2010 · RR · contact PI
Role of TbRIII in Regulating Motility and Invasion$441,531
R01 · FY2010 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$366,719
R01 · FY2010 · CA · contact PI
Role of TbRIII in Regulating Motility and Invasion$433,023
R01 · FY2009 · CA · contact PI
Function of TbRIII as a BMP Co-receptor in Human Cancer$359,685
R01 · FY2009 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$288,390
R01 · FY2009 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$288,390
R01 · FY2008 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$265,114
R01 · FY2008 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$63,954
R01 · FY2008 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$53,605
R01 · FY2008 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$288,390
R01 · FY2007 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$262,919
R01 · FY2007 · CA · contact PI
Role of the Type III TGF-Beta Receptor in Cancer Biology$239,473
R01 · FY2007 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$63,954
R01 · FY2007 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$54,505
R01 · FY2007 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$297,003
R01 · FY2006 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$270,704
R01 · FY2006 · CA · contact PI
Role of the Type III TGF-Beta Receptor in Cancer Biology$246,625
R01 · FY2006 · CA · contact PI
ALK-1 and Endoglin Signaling in Endothelial Cells$54,678
R01 · FY2006 · CA · contact PI
TbetaRIII as a Mediator/Regulator of Signaling$304,150
R01 · FY2005 · CA
ALK-1 and Endoglin Signaling in Endothelial Cells$265,848
R01 · FY2005 · CA
Role of the Type III TGF-Beta Receptor in Cancer Biology$245,710
R01 · FY2005 · CA
ALK-1 and Endoglin Signaling in Endothelial Cells$53,264
R01 · FY2005 · CA
ALK-1 and Endoglin Signaling in Endothelial Cells$257,935
R01 · FY2004 · CA
Role of the Type III TGF-Beta Receptor in Cancer Biology$215,571
R01 · FY2004 · CA
Type III TGF-Beta receptor in TGF-Beta signaling$152,521
K22 · FY2004 · CA
Type III TGF-Beta receptor in TGF-Beta signaling$152,521
K22 · FY2003 · CA
Type III TGF-Beta receptor in TGF-Beta signaling$152,521
K22 · FY2002 · CA